Michael Powell, Director at Orexigen Therapeutics, Inc. (OREX), sold 700 shares at $12.09 ($8K) on 2008-08-29, disclosed to the SEC on 2008-09-02.
Open-market sale of $8k OREX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.09 | 100 | $1K | 14.3% |
| 2 | $12.09 | 600 | $7K | 85.7% |
| Total | $12.09 avg | 700 | $8K | 100% |
| Filing → |
| OCRX | SELL | 2016-12-30 | $15K | — | Filing → |
| MIRN | BUY | 2015-10-06 | $6.0M | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |